• Inozyme Pharma, Inc.(NasdaqGS: INZY) dropped from S&P TMI Index MarketScreener Wed, 02 Jul 2025 00:22:02 GMT
• BioMarin Completes Acquisition of Inozyme Pharma for $270M Contract Pharma Tue, 01 Jul 2025 14:08:43 GMT
• BioMarin completes acquisition of Inozyme Pharma, triggers delisting from Nasdaq Investing.com Tue, 01 Jul 2025 13:43:52 GMT
• BioMarin Pharmaceutical Closes Acquisition of Inozyme Pharma MarketScreener Tue, 01 Jul 2025 13:29:29 GMT
• BioMarin completes $270 million acquisition of Inozyme Pharma Investing.com Tue, 01 Jul 2025 13:14:40 GMT
• BioMarin Acquires Inozyme for $270M, Gains Late-Stage Enzyme Therapy for Untreated Rare Disease Stock Titan Tue, 01 Jul 2025 12:45:00 GMT
• BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz MSN Mon, 30 Jun 2025 23:42:02 GMT
• Inozyme Pharma Postpones 2025 Annual Meeting of Stockholders Amid BioMarin Acquisition Discussions Nasdaq Fri, 20 Jun 2025 21:10:00 GMT
• Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders GlobeNewswire Fri, 20 Jun 2025 07:00:00 GMT
• Inozyme Pharma Halts Annual Meeting as BioMarin Acquisition Nears Completion Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• Inozyme Pharma Postpones Annual Meeting Amid BioMarin Acquisition Talks | INZY SEC Filing - Form DEFA14A Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• The BioMarin-Inozyme Deal: A Strategic Gamble or a Pipeline Lifeline? AInvest Fri, 20 Jun 2025 07:00:00 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Fri, 13 Jun 2025 17:45:18 GMT
• Inozyme Pharma (INZY) Rises 0.25% on BioMarin Acquisition News AInvest Wed, 04 Jun 2025 07:00:00 GMT
• inozyme pharma announces executive bonuses amid merger plans Investing.com Mon, 02 Jun 2025 07:00:00 GMT
• beryl capital management llc acquires significant stake in inozyme pharma inc GuruFocus Fri, 30 May 2025 00:33:05 GMT
• millennium management llc has $5.21 million stake in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 12:31:01 GMT
• northern trust corp boosts stock holdings in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 12:18:55 GMT
• d. e. shaw & co. inc. makes new investment in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 08:39:24 GMT
• beryl capital management llc acquires significant stake in inozyme pharma inc GuruFocus Thu, 29 May 2025 07:00:00 GMT
• BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXN... TradingView Tue, 27 May 2025 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates inzy, txnm, svt, ptix on behalf of shareholders TradingView Tue, 27 May 2025 07:00:00 GMT
• Inozyme Pharma and Biohaven Pharmaceuticals Announce Leadership Changes Amid Industry Restructuring geneonline.com Mon, 26 May 2025 07:00:00 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Sun, 25 May 2025 10:03:00 GMT
• biotech stock roundup: bmrn to acquire inzy, nvax gains on vaccine approval & more MSN Sun, 25 May 2025 02:36:56 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sat, 24 May 2025 11:15:08 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Thu, 22 May 2025 12:48:45 GMT
• Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More Zacks Investment Research Thu, 22 May 2025 07:00:00 GMT
• kahn swick & foti, llc investigates adequacy of price and process in proposed sale of inozyme pharma, inc. - inzy FinancialContent Wed, 21 May 2025 21:56:00 GMT
• INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price a... Business Wire Wed, 21 May 2025 07:00:00 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Wed, 21 May 2025 00:28:34 GMT
• biotech alert: searches spiking for these stocks today Yahoo Finance Tue, 20 May 2025 07:00:00 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Tue, 20 May 2025 06:08:40 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Mon, 19 May 2025 23:12:44 GMT
• biomarin expands rare disease portfolio with $270m inozyme acquisition MSN Mon, 19 May 2025 23:03:55 GMT
• biomarin to buy enzyme therapy developer inozyme in $270m all-cash deal MSN Mon, 19 May 2025 22:04:54 GMT
• piper sandler downgrades inozyme pharma to neutral from overweight, lowers price target to $4 from $23 marketscreener.com Mon, 19 May 2025 11:54:10 GMT
• biomarin to acquire inozyme to enhance its therapeutics portfolio World Pharmaceutical Frontiers Mon, 19 May 2025 09:48:16 GMT
• BioMarin agrees to acquire Inozyme for $270m Pharmaceutical Technology Mon, 19 May 2025 07:00:00 GMT
• BioMarin Strengthens Rare Disease Pipeline with $270 Million Inozyme Acquisition PharmExec Mon, 19 May 2025 07:00:00 GMT
• BioMarin to acquire Inozyme to enhance its enzyme therapy portfolio World Pharmaceutical Frontiers Mon, 19 May 2025 07:00:00 GMT
• BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz Yahoo Finance Mon, 19 May 2025 07:00:00 GMT
• Inozyme Pharma finds buyer in BioMarin after strategic review The Business Journals Mon, 19 May 2025 07:00:00 GMT
• BioMarin’s Bold Move in Rare Diseases: How the Inozyme Deal Unlocks a $4B Opportunity AInvest Mon, 19 May 2025 07:00:00 GMT
• BioMarin: Inozyme Acquisition Falls Short Of Offsetting Looming Revenue Risks (Downgrade) Seeking Alpha Mon, 19 May 2025 07:00:00 GMT
• BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXN... TradingView Mon, 19 May 2025 07:00:00 GMT
• td cowen downgrades inozyme pharma to hold from buy, price target is $4 MarketScreener Mon, 19 May 2025 07:00:00 GMT
• raymond james downgrades inozyme pharma to market perform from outperform MarketScreener Mon, 19 May 2025 07:00:00 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sun, 18 May 2025 16:47:59 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Sun, 18 May 2025 08:16:36 GMT
• StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A Genetic Engineering and Biotechnology News Sun, 18 May 2025 07:00:00 GMT
• BioMarin Expands Rare Disease Portfolio with $270M Inozyme Acquisition Insider Monkey Sun, 18 May 2025 07:00:00 GMT
• The week in pharma: action, reaction and insight – week to May 16 The Pharma Letter Sun, 18 May 2025 07:00:00 GMT
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GlobeNewswire Sun, 18 May 2025 07:00:00 GMT
• inozyme pharma (nasdaq:inzy) stock rating lowered by wedbush Defense World Sun, 18 May 2025 07:00:00 GMT
• wells fargo & company reaffirms equal weight rating for inozyme pharma (nasdaq:inzy) Defense World Sun, 18 May 2025 07:00:00 GMT
• BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover MSN Sat, 17 May 2025 22:41:30 GMT
• biomarin to buy enzyme therapy developer inozyme in $270m all-cash deal MSN Sat, 17 May 2025 22:12:29 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sat, 17 May 2025 17:09:04 GMT
• Leerink bullish on BioMarin following Inozyme deal, expects additional BD Yahoo Finance Sat, 17 May 2025 07:00:00 GMT
• biomarin stock rises following inozyme pharma acquisition Investing.com Australia Sat, 17 May 2025 07:00:00 GMT
• wedbush has negative outlook for inozyme pharma q2 earnings Defense World Sat, 17 May 2025 07:00:00 GMT
• inozyme pharma (inzy) downgraded by needham analyst | inzy stock news GuruFocus Sat, 17 May 2025 03:18:18 GMT
• jefferies downgrades inozyme pharma to neutral from buy marketscreener.com Fri, 16 May 2025 18:37:06 GMT
• BioMarin Pharmaceutical: Balancing Opportunities and Risks Amid Inozyme Acquisition and Market Challenges TipRanks Fri, 16 May 2025 18:34:03 GMT
• biomarin (bmrn) set to acquire inozyme pharma for $270m | bmrn stock news GuruFocus Fri, 16 May 2025 17:46:53 GMT
• leerink bullish on biomarin following inozyme deal, expects additional bd TipRanks Fri, 16 May 2025 17:45:14 GMT
• Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens MSN Fri, 16 May 2025 17:29:35 GMT
• inozyme downgraded to equal weight from overweight at wells fargo TipRanks Fri, 16 May 2025 15:43:48 GMT
• inozyme pharma, emerson electric, stanley black & decker TradingView Fri, 16 May 2025 15:39:04 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Fri, 16 May 2025 15:00:50 GMT
• biomarin says inozyme deal to strengthen enzyme therapies portfolio TipRanks Fri, 16 May 2025 13:55:56 GMT
• wedbush downgrades inozyme pharma to neutral from outperform, adjusts price target to $4 from $7 marketscreener.com Fri, 16 May 2025 13:27:06 GMT
• BioMarin to buy enzyme therapy developer Inozyme in $270M all-cash deal MSN Fri, 16 May 2025 12:19:21 GMT
• biomarin to acquire inozyme for $4.00 per share in cash, or $270m TipRanks Fri, 16 May 2025 11:49:22 GMT
• BioMarin to buy rare disease drugmaker Inozyme for $270M BioPharma Dive Fri, 16 May 2025 07:00:00 GMT
• BioMarin To Acquire Inozyme Pharma For About $270 Mln In Cash Nasdaq Fri, 16 May 2025 07:00:00 GMT
• BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease MedCity News Fri, 16 May 2025 07:00:00 GMT
• BioMarin grows enzyme portfolio with $270M Inozyme buy FirstWord Pharma Fri, 16 May 2025 07:00:00 GMT
• Shareholder Alert: The Ademi Firm investigates whether Inozyme Pharma, Inc. is obtaining a Fair Price for its Public Shareholders Business Wire Fri, 16 May 2025 07:00:00 GMT
• Dollar Stock Skyrockets 179% On BioMarin Takeover Investor's Business Daily Fri, 16 May 2025 07:00:00 GMT
• BioMarin's $270M Acquisition Brings First-Ever Treatment for Fatal Childhood Bone Disease to Phase 3 Stock Titan Fri, 16 May 2025 07:00:00 GMT
• BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect in first M&A move of the Sabry era Fierce Biotech Fri, 16 May 2025 07:00:00 GMT
• BioMarin stock rises following Inozyme Pharma acquisition Investing.com Fri, 16 May 2025 07:00:00 GMT
• INZY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inozyme Pharma, Inc. Is Fair to Shareholders Business Wire Fri, 16 May 2025 07:00:00 GMT
• SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inozyme Pharma, Inc. - INZY PR Newswire Fri, 16 May 2025 07:00:00 GMT
• BioMarin Pharmaceutical Inc. agreed to acquire Inozyme Pharma, Inc. for approximately $260 million. MarketScreener Fri, 16 May 2025 07:00:00 GMT
• Inozyme stock rating cut to Hold at Jefferies, target to $4 from $15 Investing.com Fri, 16 May 2025 07:00:00 GMT
• TD Cowen cuts Inozyme stock rating post-acquisition news Investing.com Fri, 16 May 2025 07:00:00 GMT
• BioMarin’s $270m Inozyme Buy Fits Right Into Enzyme Therapy Business insights.citeline.com Fri, 16 May 2025 07:00:00 GMT
• BioMarin stock in focus on M&A deal with Inozyme (BMRN:NASDAQ) Seeking Alpha Fri, 16 May 2025 07:00:00 GMT
• Inozyme Pharma (INZY) Downgraded by Wells Fargo | INZY Stock News GuruFocus Fri, 16 May 2025 07:00:00 GMT
• Biomarin snags potential ‘first-in-disease’ ERT in $270M Inozyme buy BioWorld MedTech Fri, 16 May 2025 07:00:00 GMT
• SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Inozyme Pharma, Inc. (INZY) TradingView Fri, 16 May 2025 07:00:00 GMT
• Inozyme Pharma’s Big Leap: Why INZY Is Surging on BioMarin’s Acquisition News RagingBull Fri, 16 May 2025 07:00:00 GMT
• BioMarin to acquire Inozyme for $270 million By Investing.com Investing.com Australia Fri, 16 May 2025 07:00:00 GMT
• BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme Endpoints News Fri, 16 May 2025 07:00:00 GMT
• biomarin’s bold move: a strategic play to dominate rare disease therapies with inozyme’s breakthrough inz-701 AInvest Fri, 16 May 2025 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates chtr and inzy on behalf of shareholders The Malaysian Reserve Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma’s strategic acquisition by biomarin: analyst holds rating amid favorable shareholder outcome and strategic alignmen... TipRanks Fri, 16 May 2025 07:00:00 GMT
• biomarin strengthens enzyme therapy business with acquisition of inozyme pharma Yahoo Finance Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded after biomarin acquisition announcement | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• sector update: health care stocks flat to higher premarket friday marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• transcript : biomarin pharmaceutical inc., inozyme pharma, inc. - m&a call marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded by wells fargo following acquisition news | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• jefferies downgrades inozyme (inzy) after acquisition announceme GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition deal | inzy stoc GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma (inzy) downgraded by needham analyst | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma (inzy) sees price target slash and downgrade by jefferies | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin pharmaceutical (bmrn) set to acquire inozyme pharma for GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition agreement | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin pharmaceutical to acquire inozyme pharma for $270 million marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition by biomarin | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin (bmrn) expands enzyme therapy portfolio with inozyme ac GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) shares purchased by dimensional fund advisors lp Defense World Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma’s inz-701 shows promising results in energy-3 study, highlighting investment potential TipRanks Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) given consensus recommendation of “buy” by brokerages Defense World Thu, 15 May 2025 08:49:33 GMT
• inozyme (inzy) advances energy 3 trial for enpp1 deficiency trea GuruFocus Thu, 15 May 2025 01:43:29 GMT
• Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights GlobeNewswire Wed, 14 May 2025 07:00:00 GMT
• INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients Contemporary Pediatrics Wed, 14 May 2025 07:00:00 GMT
• Inozyme Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 MarketScreener Wed, 14 May 2025 07:00:00 GMT
• Inozyme (INZY) Advances ENERGY 3 Trial for ENPP1 Deficiency Treatment | INZY Stock News GuruFocus Wed, 14 May 2025 07:00:00 GMT
• breakthrough clinical data: inozyme's energy 3 trial reveals first potential treatment for enpp1 deficiency Stock Titan Wed, 14 May 2025 07:00:00 GMT
• inozyme pharma’s strategic focus and promising trial data earns buy rating TipRanks Wed, 14 May 2025 07:00:00 GMT
• inozyme pharma, inc. provides preliminary anti-drug antibody data from the energy 3 trial MarketScreener Wed, 14 May 2025 07:00:00 GMT
• inzy: analyst lowers price target, maintains buy rating | inzy stock news GuruFocus Wed, 14 May 2025 07:00:00 GMT
• inzy's financial outlook supported by strong cash reserves | inz GuruFocus Wed, 14 May 2025 07:00:00 GMT
• inozyme pharma, inc. announces chief medical officer changes marketscreener.com Wed, 14 May 2025 07:00:00 GMT
• raymond james financial inc. buys new position in inozyme pharma, inc. (nasdaq:inzy) Defense World Tue, 13 May 2025 07:00:00 GMT
• barclays plc has $254,000 holdings in inozyme pharma, inc. (nasdaq:inzy) Defense World Mon, 12 May 2025 07:31:52 GMT
• what analysts were expecting after inozyme pharma inc (nasdaq: inzy) fell -7.26% Stocksregister Sat, 10 May 2025 11:04:49 GMT
• stock performance spotlight: inozyme pharma inc (inzy) ends the day at 1.26, down by -15.44 DWinneX Wed, 07 May 2025 12:41:17 GMT
• INZY - Inozyme Pharma, Inc. Latest Stock News & Market Updates Stock Titan Mon, 05 May 2025 13:55:16 GMT
• inozyme pharma (inzy) projected to post earnings on tuesday Defense World Sun, 04 May 2025 07:00:00 GMT
• jpmorgan chase & co. acquires 99,944 shares of inozyme pharma, inc. (nasdaq:inzy) Defense World Fri, 02 May 2025 07:00:00 GMT
• charles barkley is ro’s glp-1 celebrity ambassador Pharmaceutical Executive Fri, 02 May 2025 07:00:00 GMT
• inozyme pharma inc’s shares reel: -19.01% quarterly revenue decline amid 73.87m market cap investchronicle.com Thu, 01 May 2025 13:42:31 GMT
• inzy stock sees surge of approximately 17.28% in last five days knoxdaily.com Thu, 01 May 2025 13:24:24 GMT
• eventide asset management, llc reduces stake in inozyme pharma i GuruFocus Wed, 30 Apr 2025 07:00:00 GMT
• renaissance technologies llc buys 256,599 shares of inozyme pharma, inc. (nasdaq:inzy) Defense World Wed, 30 Apr 2025 07:00:00 GMT
• inzy - inozyme pharma, inc. latest stock news & market updates Stock Titan Thu, 24 Apr 2025 17:21:23 GMT
• inozyme pharma inc [nasdaq: inzy] sees decrease in stock value knoxdaily.com Thu, 24 Apr 2025 13:17:45 GMT
• financial snapshot: analyzing inozyme pharma inc (inzy)’s key ratio metrics DWinneX Thu, 24 Apr 2025 11:49:09 GMT
• inozyme pharma, inc. (nasdaq:inzy) receives consensus rating of “buy” from brokerages Defense World Sun, 20 Apr 2025 07:00:00 GMT
• is now a good time to invest in inozyme pharma inc (nasdaq: inzy)? Stocksregister Sat, 19 Apr 2025 16:03:04 GMT
• wellington management group llp lowers holdings in inozyme pharma, inc. (nasdaq:inzy) Defense World Tue, 15 Apr 2025 07:00:00 GMT
• inozyme pharma inc (nasdaq: inzy) has fallen -601.12% from its highs, what comes next? Marketing Sentinel Sat, 12 Apr 2025 07:00:00 GMT
• raymond james financial inc. invests $205,000 in inozyme pharma, inc. (nasdaq:inzy) Defense World Sat, 12 Apr 2025 07:00:00 GMT
• inozyme pharma (inzy) publishes comprehensive study on enpp1 def GuruFocus Fri, 11 Apr 2025 08:31:11 GMT
• inozyme pharma announces jbmr plus publication demonstrating rea GuruFocus Fri, 11 Apr 2025 08:09:40 GMT
• h.c. wainwright maintains buy on inozyme stock with $16 target Investing.com Fri, 11 Apr 2025 07:00:00 GMT
• inozyme announces jbmr plus publication on enpp1 deficiency TipRanks Thu, 10 Apr 2025 15:50:58 GMT
• promising potential of inz-701 in treating enpp1 deficiency drives buy rating for inozyme pharma TipRanks Thu, 10 Apr 2025 14:57:43 GMT
• inozyme pharma (inzy) publishes comprehensive study on enpp1 def GuruFocus Thu, 10 Apr 2025 13:38:08 GMT
• Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency GlobeNewswire Thu, 10 Apr 2025 07:00:00 GMT
• buy rating on inozyme pharma: promising potential of inz-701 and market opportunity TipRanks Tue, 08 Apr 2025 07:00:00 GMT
• inzy stock touches 52-week low at $0.77 amid market challenges Investing.com Mon, 07 Apr 2025 07:00:00 GMT
• Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference GlobeNewswire Mon, 31 Mar 2025 07:00:00 GMT
• march pharmaceutical industry movers & shakers Pharmaceutical Executive Mon, 31 Mar 2025 07:00:00 GMT
• rare disease innovator inozyme pharma reveals latest progress at elite healthcare conference Stock Titan Mon, 31 Mar 2025 07:00:00 GMT
• how improving financial management directly impacts drug pricing PharmExec Thu, 27 Mar 2025 07:00:00 GMT
• inspiration and problem solving: condor's core functionalities Pharmaceutical Executive Wed, 26 Mar 2025 07:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) given consensus recommendation of “buy” by brokerages Defense World Wed, 26 Mar 2025 07:00:00 GMT
• inozyme pharma inc (nasdaq: inzy) has decreased by -82.88 percent this year. is it a better buy than others? Marketing Sentinel Sat, 22 Mar 2025 07:00:00 GMT
• practical steps for better cross-functional collaboration Pharmaceutical Executive Thu, 20 Mar 2025 07:00:00 GMT
• inozyme pharma stock hits 52-week low at $0.98 amid sharp decline Investing.com Tue, 18 Mar 2025 07:00:00 GMT
• fy2027 eps estimates for inozyme pharma raised by analyst Defense World Sat, 15 Mar 2025 07:00:00 GMT
• dual trial strategy: company-sponsored and investigator-initiated Pharmaceutical Executive Fri, 14 Mar 2025 07:00:00 GMT
• q1 eps estimates for inozyme pharma reduced by hc wainwright Defense World Fri, 14 Mar 2025 07:00:00 GMT
• raymond james issues pessimistic forecast for inozyme pharma (nasdaq:inzy) stock price Defense World Fri, 14 Mar 2025 07:00:00 GMT
• q1 earnings estimate for inozyme pharma issued by wedbush Defense World Fri, 14 Mar 2025 07:00:00 GMT
• finance watch: sutro halves workforce, cuts lead adc and ceo moves on insights.citeline.com Thu, 13 Mar 2025 07:00:00 GMT
• piper sandler has lowered expectations for inozyme pharma (nasdaq:inzy) stock price Defense World Thu, 13 Mar 2025 07:00:00 GMT
• inozyme pharma (nasdaq:inzy) price target lowered to $15.00 at needham & company llc Defense World Thu, 13 Mar 2025 05:06:30 GMT
• inozyme price target lowered to $12 from $24 at raymond james TipRanks Wed, 12 Mar 2025 13:41:33 GMT
• Corrected: Mineralys aims to raise $250M; Coherus’ staffing changes Endpoints News Wed, 12 Mar 2025 07:00:00 GMT
• inozyme pharma (nasdaq:inzy) price target lowered to $15.00 at needham & company llc Defense World Wed, 12 Mar 2025 07:00:00 GMT
• inozyme pharma’s (inzy) “buy” rating reaffirmed at hc wainwright Defense World Wed, 12 Mar 2025 07:00:00 GMT
• piper sandler cuts inozyme pharma stock target to $23 by investing.com Investing.com Canada Wed, 12 Mar 2025 06:43:01 GMT
• inozyme pharma stock hits 52-week low at $1.03 amid sharp decline Investing.com Wed, 12 Mar 2025 02:11:08 GMT
• h.c. wainwright maintains buy on inozyme stock with $16 target Investing.com Tue, 11 Mar 2025 07:00:00 GMT
• inozyme pharma stock hits 52-week low at $1.03 amid sharp decline by investing.com Investing.com South Africa Tue, 11 Mar 2025 07:00:00 GMT
• wedbush reaffirms outperform rating for inozyme pharma (nasdaq:inzy) The AM Reporter Tue, 11 Mar 2025 07:00:00 GMT
• inozyme pharma (nasdaq:inzy) given outperform rating at wedbush Defense World Tue, 11 Mar 2025 07:00:00 GMT
• inozyme price target lowered to $23 from $30 at piper sandler TipRanks Tue, 11 Mar 2025 07:00:00 GMT
• Inozyme Cuts 25% Workforce, Reports Progress in ENPP1 Trial Stock Titan Mon, 10 Mar 2025 07:00:00 GMT
• Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program... GlobeNewswire Mon, 10 Mar 2025 07:00:00 GMT
• Inozyme Pharma Inc reports results for the quarter ended December 31 - Earnings Summary TradingView Mon, 10 Mar 2025 07:00:00 GMT
• inozyme pharma reports 2024 financial results and strategic prioritization of enpp1 deficiency program Nasdaq Mon, 10 Mar 2025 07:00:00 GMT
• wedbush cuts inozyme pharma price target to $7 from $12, maintains outperform rating MarketScreener Mon, 10 Mar 2025 07:00:00 GMT
• inozyme reports prioritization of enpp1 deficiency program, workforce reduction TipRanks Mon, 10 Mar 2025 07:00:00 GMT
• inozyme pharma (inzy) projected to post earnings on tuesday Defense World Sun, 09 Mar 2025 08:00:00 GMT
• inozyme pharma inc expected to post a loss of 41 cents a share - earnings preview TradingView Fri, 07 Mar 2025 08:00:00 GMT
• rare disease biotechs left in a lurch as congress fails to renew priority review program BioSpace Wed, 05 Mar 2025 08:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) receives $18.33 consensus pt from analysts Armenian Reporter Tue, 04 Mar 2025 08:00:00 GMT
• INZY stock touches 52-week low at $1.14 amid market challenges Investing.com Mon, 03 Mar 2025 08:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) given average rating of “buy” by brokerages Defense World Sat, 01 Mar 2025 07:28:59 GMT
• inozyme pharma stock hits 52-week low at $1.23 amid challenges Investing.com Canada Tue, 25 Feb 2025 01:06:09 GMT
• inozyme pharma to present at the td cowen 45th annual health care conference GlobeNewswire Mon, 24 Feb 2025 08:00:00 GMT
• inozyme pharma stock hits 52-week low at $1.23 amid challenges Investing.com Mon, 24 Feb 2025 08:00:00 GMT
• can inozyme's rare disease pipeline transform bone health treatment? ceo presents key data Stock Titan Mon, 24 Feb 2025 08:00:00 GMT
• Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP ... GlobeNewswire Fri, 21 Feb 2025 08:00:00 GMT
• can this rare disease treatment transform young lives? new enpp1 therapy data emerges Stock Titan Fri, 21 Feb 2025 08:00:00 GMT
• inozyme pharma stock hits 52-week low at $1.32 amid market challenges MSN Mon, 17 Feb 2025 09:08:27 GMT
• abrdn plc makes new $472,000 investment in inozyme pharma, inc. (nasdaq:inzy) Defense World Wed, 12 Feb 2025 08:00:00 GMT
• inozyme pharma inc (nasdaq: inzy) stock falling -48.58% over a month – any room for its value to rise? Marketing Sentinel Sat, 08 Feb 2025 13:04:40 GMT
• inozyme pharma, inc. (nasdaq:inzy) given consensus recommendation of "buy" by brokerages MarketBeat Sat, 08 Feb 2025 07:11:39 GMT
• inozyme pharma, inc. (nasdaq:inzy) given consensus recommendation of "buy" by brokerages MarketBeat Fri, 07 Feb 2025 08:00:00 GMT
• inzy stock: a comprehensive analysis and forecast The InvestChronicle Thu, 06 Feb 2025 16:41:36 GMT
• was anything positive for inozyme pharma inc (inzy) stock last session? US Post News Thu, 06 Feb 2025 14:25:30 GMT
Inozyme Pharma, Inc(NASDAQ:INZY) 
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare gen...
Website: http://www.inozyme.com
Founded: 2015
CEO: Axel Bolte
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends